Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tramadol and Naproxen Sodium for Local Anesthesia Efficacy in Irreversible Pulpitis
NCT05982392Phase 3Completed
- Sponsor
- Dow University of Health Sciences
- Start
- Mar 2023
- Primary completion
- Aug 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of tramadol, Aprol in irreversible pulpitis, postoperative pain, sponsored by Dow University of Health Sciences. Started Mar 2023; status: completed.
02
Drugs
tramadolAprol
03
Conditions
irreversible pulpitispostoperative pain
Beyond the preview
Go deeper on NCT05982392.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05982392.